Subscribe to RSS
DOI: 10.1055/a-2741-1586
Inpatient Medicare TKA Patients Have Distinct Characteristics and Worse Outcomes: Implications for the New CMS PROMs Policy
Authors
Abstract
The Centers for Medicare and Medicaid Services (CMS) recently mandated the collection of Patient-Reported Outcome-Based Performance Measures (PRO-PMs) for Medicare patients undergoing inpatient total knee arthroplasty (TKA). The policy's generalizability remains a concern. Therefore, we aimed to compare PROMs capture rates, patients' characteristics, and achieving the substantial clinical benefit (SCB) threshold between inpatient and outpatient Medicare TKA. A prospective cohort of Medicare patients aged ≥ 65 who underwent primary TKA between 2016 and 2022 at a single health system was analyzed (n = 7,926). Patients were categorized as inpatient (length of stay [LOS] > 24 hours, n = 2,812) or outpatient (LOS ≤ 24 hours, n = 5,114). Capture rates of CMS-mandated variables, baseline characteristics, and 1-year outcomes were compared. SCB was defined as a 20-point improvement in the Knee Injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS-JR) per CMS criteria. Baseline capture rates were similar between groups (approximately 82.8%), but 1-year KOOS-JR completion was lower for inpatients (53.3% vs. 62.4%). Inpatients had higher comorbidity burden (CCI ≥ 2: 40% vs. 33%, p < 0.001), worse KOOS-JR (median 44.9 vs. 47.5, p < 0.001), lower VR-12 MCS scores (50.2 vs. 54.1, p < 0.001), and more frequent nonoperative joint pain (75.1% vs. 68.6%, p < 0.001) and back pain (67.4% vs. 63.8%, p < 0.001). Outpatients trended toward better SCB achievement (OR: 0.89, 95% CI: 0.78–1.00, p = 0.054). Compared to outpatients, inpatient Medicare TKA patients had lower 1-year PROM capture rates, more comorbidities, and worse baseline PROMs, with a trend toward not meeting CMS SCB thresholds. These differences highlight limitations in using inpatient-only data to assess national TKA outcomes, especially as outpatient procedures grow. Nonetheless, future studies with higher power should validate these findings. The level of evidence is III (retrospective).
Ethical Approval
Our institutional review board committee approved this study.
Note
Cleveland Clinic Adult Reconstruction Research (CCARR) Group: Kurt P. Spindler, MD, Trevor G. Murray, MD, Robert M. Molloy, MD, Kim L. Stearns, MD, Viktor E. Krebs, MD, Nicholas R. Scarcella, MD, Michael Erossy, MD, Alexander L. Roth, MD, Matthew E. Deren, MD, Michael R. Bloomfield, MD, Carlos A. Higuera, MD, John P. McLaughlin, DO, Peter A. Surace, MD.
Publication History
Received: 07 May 2025
Accepted: 06 November 2025
Article published online:
24 November 2025
© 2025. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Rullán PJ, Deren ME, Zhou G. et al. The arthroplasty surgeon growth indicator: a tool for monitoring supply and demand trends in the orthopaedic surgeon workforce from 2020 to 2050. J Bone Joint Surg Am 2023; 105 (13) 1038-1045
- 2 Shichman I, Roof M, Askew N. et al. Projections and epidemiology of primary hip and knee arthroplasty in Medicare patients to 2040-2060. JBJS Open Access 2023; 8 (01) e22.00112
- 3 Rullán PJ, Xu JR, Emara AK. et al. Major national shifts to outpatient total knee arthroplasties in the United States: a 10-year trends analysis of procedure volumes, complications, and healthcare utilizations (2010 to 2020). J Arthroplasty 2023; 38 (07) 1209-1216.e5
- 4 Keulen MHF, Schotanus MGM, van Haaren EH, van Hemert WLW, Heyligers IC, Boonen B. Rates and causes of 90-day complications and readmissions following outpatient hip and knee arthroplasty: a retrospective analysis of 525 patients in a single institution. J Arthroplasty 2021; 36 (03) 863-878
- 5 Theosmy E, Yayac M, Krueger CA, Courtney PM. Is the new outpatient prospective payment system classification for outpatient total knee arthroplasty appropriate?. J Arthroplasty 2021; 36 (01) 42-46
- 6 Yates AJ, Kerr JM, Froimson MI, Della Valle CJ, Huddleston JI. The unintended impact of the removal of total knee arthroplasty from the Center for Medicare and Medicaid Services inpatient-only list. J Arthroplasty 2018; 33 (12) 3602-3606
- 7 Pasqualini I, Piuzzi NS. New CMS policy on the mandatory collection of patient-reported outcome measures for total hip and knee arthroplasty by 2027: what orthopaedic surgeons should know. J Bone Joint Surg Am 2024; 106 (13) 1233-1241
- 8 THA/TKA PRO-PM Overview [Internet]. [cited 2024 Sep 30]. Accessed November 17, 2025 at: https://qualitynet.cms.gov/inpatient/measures/THA_TKA
- 9 Elmenawi KA, Pasqualini I, Khan ST. et al; Cleveland Clinic Adult Reconstruction Research Group. Comparing Medicare and non-Medicare inpatient total knee arthroplasty: is the new Centers for Medicare and Medicaid Services patient-reported outcomes performance measure mandate applicable to all?. J Arthroplasty 2025; 40 (11) 2799-2804
- 10 Elmenawi KA, Pasqualini I, Khan ST. et al. Lower 1-year PROM completion rates and need for intensive follow-up in inpatient Medicare THA patients: implications for the CMS PROM policy. JBJS Open Access 2025; 10 (03) e25.00127
- 11 Rullán PJ, Emara AK, Zhou G. et al. National inpatient datasets may no longer be appropriate for overall total hip and knee arthroplasties projections after removal from inpatient-only lists. J Knee Surg 2024; 37 (03) 214-219
- 12 Boyles M. Breaking Down the CMS Final Rule: The PRO-PM For Outpatient THA/TKA [Internet]. CODE Technology | We Collect Patient Reported Outcomes. 2023 [cited 2025 Feb 13]. Accessed November 17, 2025 at: https://www.codetechnology.com/blog/breaking-down-the-cms-final-rule-the-pro-pm-for-outpatient-tha-tka/
- 13 Anis HK, Strnad GJ, Klika AK. et al; Cleveland Clinic OME Arthroplasty Group. Developing a personalized outcome prediction tool for knee arthroplasty. Bone Joint J 2020; 102-B (09) 1183-1193
- 14 Rullán PJ, Pasqualini I, Zhang C, Klika AK, Piuzzi NS. The Cleveland Clinic OME Arthroplasty Group. How to raise the bar in the capture of patient-reported outcome measures in total joint arthroplasty: results from active and passive follow-up measures. J Bone Joint Surg Am 2024; 106 (10) 879-890
- 15 Cleveland OME. OME Cleveland Clinic Orthopaedics. Implementing a scientifically valid, cost-effective, and scalable data collection system at point of care: the Cleveland Clinic OME cohort. J Bone Joint Surg Am 2019; 101 (05) 458-464
- 16 Cleveland OME. OME Cleveland Clinic Orthopaedics. Value in research: achieving validated outcome measurements while mitigating follow-up cost. J Bone Joint Surg Am 2020; 102 (05) 419-427
- 17 Hadad MJ, Pasqualini I, Klika AK. et al. High area deprivation index is associated with not achieving the patient-acceptable symptom state after TKA. Clin Orthop Relat Res 2024; 482 (08) 1428-1438
- 18 Jevnikar BE, Huffman N, Roth A. et al; CCARR Corporate Authorship. Impacts of neighborhood deprivation on septic and aseptic revision total knee arthroplasty outcomes: a comprehensive analysis using the area deprivation index. Knee 2024; 51: 74-83
- 19 Benyamini B, Hadad MJ, Pasqualini I, Khan ST, Jin Y, Piuzzi NS. Cleveland Clinic Adult Reconstruction Research. Neighborhood socioeconomic disadvantage may influence 1-year patient-reported outcome measures after total hip arthroplasty. J Arthroplasty 2025; 40 (04) 837-847
- 20 Grits D, Emara AK, Klika AK, Murray TG, McLaughlin JP, Piuzzi NS. Neighborhood socioeconomic disadvantage associated with increased healthcare utilization after total hip arthroplasty. J Arthroplasty 2022; 37 (10) 1980-1986.e2
- 21 Khlopas A, Grits D, Sax OC. et al. Neighborhood socioeconomic disadvantages associated with prolonged lengths of stay, nonhome discharges, and 90-day readmissions after total knee arthroplasty. J Arthroplasty 2022; 37 (6S): S37-S43 , 43.e1
- 22 Hadad MJ, Rullán-Oliver P, Grits D. et al. Racial disparities in outcomes after THA and TKA are substantially mediated by socioeconomic disadvantage both in Black and White patients. Clin Orthop Relat Res 2023; 481 (02) 254-264
- 23 Emara AK, Klika AK, Piuzzi NS. A call for improved screening of preoperative prescription drug abuse: a scalar assessment not limited to opioids. Ann Surg Open 2021; 2 (02) e061
- 24 Emara AK, Santana D, Grits D. et al. Exploration of overdose risk score and postoperative complications and health care use after total knee arthroplasty. JAMA Netw Open 2021; 4 (06) e2113977
- 25 Emara AK, Grits D, Klika AK. et al. NarxCare scores greater than 300 are associated with adverse outcomes after primary THA. Clin Orthop Relat Res 2021; 479 (09) 1957-1967
- 26 Khan ST, Pasqualini I, Rullán PJ, Tidd J, Piuzzi NS. Cleveland Clinic Arthroplasty Group. Predictive modeling of medical and orthopaedic-related 90-day-readmissions following primary total knee arthroplasty. J Arthroplasty 2025; 40 (02) 286-293.e2
- 27 Pasqualini I, Piuzzi NS. Patient-reported outcome measures: state of the art in patient-reported outcome measure application in lower extremity orthopaedics. J Am Acad Orthop Surg 2023; 31 (20) e883-e889
- 28 Orr MN, Klika AK, Gagnier JJ, Bhandari M, Piuzzi NS. A call for a standardized approach to reporting patient-reported outcome measures: clinical relevance ratio. J Bone Joint Surg Am 2021; 103 (22) e91
- 29 Emara AK, Klika AK, Piuzzi NS. Evidence-Based Orthopedic Surgery-From Synthesis to Practice. JAMA Surg 2020; 155 (11) 1009-1010
- 30 Soares RW, Emara AK, Orr M. et al. When do we perform elective total knee arthroplasty? general and demographic-specific trends of preoperative pain and function among 10,327 patients. J Knee Surg 2023; 36 (14) 1454-1461
- 31 Emara AK, Orr MN, Klika AK, McLaughlin JP, Molloy RM, Piuzzi NS. When is surgery performed? trends, demographic associations, and phenotypical characterization of baseline patient-reported outcomes before total hip arthroplasty. J Arthroplasty 2022; 37 (06) 1083-1091.e3
- 32 Gordon AM, Ng MK, Elali F, Piuzzi NS, Mont MA. A nationwide analysis of the impact of socioeconomic status on complications and health care utilizations after total knee arthroplasty using the area deprivation index: consideration of the disadvantaged patient. J Arthroplasty 2024; 39 (09) 2166-2172
- 33 Orr MN, Klika AK, Emara AK, Piuzzi NS. Cleveland Clinic Arthroplasty Group. Combinations of preoperative patient-reported outcome measure phenotype (pain, function, and mental health) predict outcome after total knee arthroplasty. J Arthroplasty 2022; 37 (6S): S110-S120 , 120.e5
- 34 Klemt C, Cohen-Levy WB, Pattavina MH, Oliveira BMC, Uzosike AC, Kwon YM. The same day discharges following primary total knee arthroplasty: a single surgeon, propensity score-matched cohort analysis. J Knee Surg 2023; 36 (13) 1380-1385